SlideShare ist ein Scribd-Unternehmen logo
1 von 35
CNS
STIMULANTS
Mr. Mangesh Bansod,
Asst. Prof.
SDDVCPRC, Panvel
 These are drugs whose primary action is to
stimulate the CNS or to improve specific brain
functions.
 The CNS stimulants mostly produce a
generalized action which may, at high doses,
result in convulsions.
Classification
CONVULSANTS
Strychnine -
 It is an alkaloid from the seeds of Strychnos nux-vomica, and a
potent convulsant.
 The convulsions are reflex, tonic-clonic and symmetrical. It
labelled as a spinal convulsant because it stimulates the whole
cerebrospinal axis.
 Strychnine acts by blocking post-synaptic inhibition produced by
the inhibitory transmitter glycine.
 Due to loss of synaptic inhibition, any nerve impulse becomes
generalized, resulting in apparent excitation and convulsions.
 There are no valid uses of strychnine now.
 Accidental poisonings, especially in children, do occur.
 Treatment of poisoning is similar to that of status epilepticus
Picrotoxin -
 Obtained from ‘fish berries’ of East Indies
Anamirta cocculus.
 It is a potent convulsant— convulsions are
clonic, spontaneous and asymmetrical.
 The convulsions are accompanied by
vomiting, respiratory and vasomotor
stimulation.
 Picrotoxin acts by blocking presynaptic
inhibition mediated through GABA.
 However, it is not a competitive antagonist;
does not act on GABA receptor itself, but on
a distinct site and prevents Cl¯ channel
opening.
 Diazepam, which facilitates GABAergic
transmission, is the drug of choice for
picrotoxin poisoning.
CONVULSANTS
Pentylenetetrazol (PTZ) -
 It is a powerful CNS stimulant, believed to be
acting by direct depolarization of central
neurones.
 However, it has also been shown to interfere with
GABAergic inhibition—may be acting in a manner
analogous to picrotoxin.
 Low doses cause excitation, larger doses produce
convulsions which are similar in pattern to those
caused by picrotoxin.
 Antagonism of PTZ induced convulsions is an
established method of testing anticonvulsant
drugs in laboratory animals
CONVULSANTS
ANALEPTICS (Respiratory
stimulants)
 These are drugs which stimulate respiration and can have
resuscitative value in coma or fainting.
 They do stimulate respiration in subconvulsive doses, but margin of
safety is narrow; the patient may get convulsions while still in coma.
 Mechanical support to respiration and other measures to improve
circulation are more effective and safe.
 The role of analeptics in therapeutics is very limited.
 Situations in which they may be employed are:
(a) in hypnotic drug poisoning untill mechanical ventilation is
instituted.
(b) Suffocation on drowning, acute respiratory insufficiency.
(c) Apnoea in premature infant.
(d) Failure to ventilate spontaneously after general anaesthesia.
 However, the overall utility of analeptics is dubious.
Doxapram
 It acts by promoting excitation of central
neurones.
 it is more selective for the respiratory centre.
 Respiration is stimulated through carotid and
aortic body chemoreceptors as well.
 Falling BP rises.
 Continuous i.v. infusion of doxapram may
abolish episodes of apnoea in premature infant
not responding to theophylline.
PSYCHOSTIMULANTS
 the psychomotor stimulants, cause excitement
and euphoria, decrease feelings of fatigue, and
increase motor activity.
 Amphetamines
 These are central sympathomimetics.
 shows neurologic and clinical effects quite similar
to those of cocaine.
 Dextroamphetamine is the major member of this
class of compounds.
 Methamphetamine is a derivative of amphetamine
that can be smoked, and it is preferred by many
abusers.
•The major behavioral effects of
amphetamine result from a combination
of its dopamine and norepinephrine
release-enhancing properties.
•Amphetamine stimulates the entire
cerebrospinal axis, cortex, brainstem, and
medulla.
•This leads to increased alertness,
decreased fatigue, depressed appetite,
and insomnia.
•These CNS stimulant effects of
amphetamine and its derivatives have led
to their use in therapy for hyperactivity in
children, narcolepsy, and for appetite
Attention deficit hyperactivity
disorder (ADHD):
 Some young children are hyperkinetic and lack
the ability to be involved in any one activity for
longer than a few minutes.
 Dextroamphetamine and the amphetamine
derivative methylphenidate are able to improve
attention and to alleviate many of the behavioral
problems associated with this syndrome, and to
reduce the hyperkinesia that such children
demonstrate.
 The drug prolongs the patient's span of attention
allowing better function in a school atmosphere.
Narcolepsy
 Narcolepsy is a relatively rare sleep disorder that is
characterized by uncontrollable bouts of sleepiness
during the day.
 It is sometimes accompanied by catalepsy, a loss in
muscle control, or even paralysis brought on by strong
emotions, such as laughter.
 However, it is the sleepiness for which the patient is
usually treated with drugs such as amphetamine or
methylphenidate. Recently, a newer drug, modafinil and
its R-enantiomer derivative, armodafinil, have become
available to treat narcolepsy.
 Modafinil produces fewer psychoactive and euphoric
effects as well as, alterations in mood, perception,
thinking, and feelings typical of other CNS stimulants. It
does promote wakefulness.
Adverse effects
Methylphenidate
 It is chemically and pharmacologically similar to
amphetamine.
 Both act primarily by releasing NA and DA in the brain.
 Both produce increase in mental activity at doses which
have little action on other central and peripheral functions.
 Methylphenidate is considered superior to amphetamine
for attention deficit hyperkinetic disorder (ADHD) because
it causes lesser tachycardia and growth retardation.
 Behaviour and learning ability are improved in 3 out of 4
treated children.
 It can also be used for concentration and attention defect
in adults, and for narcolepsy
 Side effects are anorexia, insomnia, growth retardation,
abdominal discomfort and bowel upset.
Modafinil
 This newer psychostimulant is popular with night-shift (call centre)
workers and other professionals who want to improve alertness
and keep awake.
 It is claimed to increase attention span and improve accuracy that
has been compromized by fatigue and sleepiness.
 Although, modafinil has been shown to inhibit NA and DA uptake
as well as alter junctional concentration of glutamate and GABA, its
actual mechanism of action is not known.
 The approved indications are day-time sleepiness due to
narcolepsy, sleep apnoea syndrome and shift-work disorder
(SWD).
 It has also been found to reduce euphoria produced by cocaine
and to suppress cocaine withdrawal symptoms; is being evaluated
as a drug to prevent relapse of cocaine dependence.
Cocaine
 The primary mechanism of action
underlying the central and peripheral
effects of cocaine is blockade of reuptake
of the monoamines (norepinephrine,
serotonin, and dopamine) into the
presynaptic terminals from which these
neurotransmitters are released.
 potentiates and prolongs the CNS and
peripheral actions of these monoamines.
 the prolongation of dopaminergic effects
in the brain's pleasure system (limbic
system) produces the intense euphoria
that cocaine initially causes.
 Chronic intake of cocaine depletes
dopamine. This depletion triggers the
vicious cycle of craving for cocaine that
temporarily relieves severe depression
Actions: Cocaine
 CNS: The behavioral effects of cocaine result
from powerful stimulation of the cortex and
brainstem.
 Cocaine acutely increases mental awareness
and produces a feeling of well-being and
euphoria similar to that caused by
amphetamine.
 Like amphetamine, cocaine can produce
hallucinations and delusions of paranoia or
grandiosity.
 Cocaine increases motor activity, and at high
doses, it causes tremors and convulsions,
Cocaine
 Sympathetic nervous system: Peripherally,
cocaine potentiates the action of norepinephrine,
and it produces the fight or flight syndrome
characteristic of adrenergic stimulation.
 This is associated with tachycardia, hypertension,
pupillary dilation, and peripheral vasoconstriction.
Recent evidence suggests that the ability of
baroreceptor reflexes to buffer the hypertensive
effect may be impaired.
 Hyperthermia: Cocaine is unique among illicit
drugs in that death can result not only as a function
of dose but also from the drug's propensity to cause
hyperthermia.
Cocaine
 Therapeutic uses: Cocaine has a local
anesthetic action that represents the only
current rationale for the therapeutic use of
cocaine.
 For example, cocaine is applied topically as a
local anesthetic during eye, ear, nose, and
throat surgery.
 Whereas the local anesthetic action of cocaine
is due to a block of voltage-activated sodium
channels,
 an interaction with potassium channels may
contribute to the ability of cocaine to cause
Pharmacokinetics: Cocaine
 Cocaine is often self-administered by chewing,
intranasal snorting, smoking, or intravenous (IV)
injection.
 The peak effect occurs at 15 to 20 minutes after
intranasal intake of cocaine powder, and the
disappears in 1 to 1.5 hours.
 the onset of action is most rapid, the potential for
overdosage and dependence is greatest with IV
injection and crack smoking.
 Cocaine is rapidly de-esterified and demethylated
to benzoylecgonine, which is excreted in the urine.
 Detection of this substance in the urine identifies a
user.
Adverse effects:
Cocaine
 Anxiety
 Depression
 Toxic
effects
Major effects of cocaine use.
Caffeine
 The methylxanthines include theophylline which is
found in tea; theobromine , found in cocoa; and
caffeine.
 Out of the three naturally occurring
methylxanthines, only caffeine is used as a CNS
stimulant.
 Mechanism of action: translocation of
extracellular calcium, increase in cyclic adenosine
monophosphate and cyclic guanosine
monophosphate caused by inhibition of
phosphodiesterase, and blockade of adenosine
receptors.
Actions: Caffeine
 CNS: The caffeine contained in one to two cups
of coffee (100–200 mg) causes a decrease in
fatigue and increased mental alertness as a result of
stimulating the cortex and other areas of the brain.
 Consumption of 1.5 g of caffeine (12 to 15 cups of
coffee) produces anxiety and tremors.
 The spinal cord is stimulated only by very high doses
of caffeine.
 Tolerance can rapidly develop to the stimulating
properties of caffeine; withdrawal consists of feelings
of fatigue and sedation.
 Cardiovascular system: A high dose of caffeine has
positive inotropic and chronotropic effects on the
heart.
 Diuretic action: Caffeine has a mild diuretic action
that increases urinary output of sodium, chloride, and
potassium.
 Gastric mucosa: Because all methylxanthines
stimulate secretion of hydrochloric acid from the
gastric mucosa, individuals with peptic ulcers should
a
 Pharmacokinetics: The methylxanthines are well
absorbed orally. Caffeine distributes throughout the
body, including the brain.
 The drugs cross the placenta to the fetus and is
secreted into the mother's milk.
 All the methylxanthines are metabolized in the liver,
generally by the CYP1A2 pathway, and the
Caffeine
 Adverse effects: Moderate doses of caffeine
cause insomnia, anxiety, and agitation.
 A high dosage is required for toxicity, which is
manifested by emesis and convulsions.
 Lethargy, irritability, and headache occur in
users who have routinely consumed caffeine .
Caffeine
•A few drugs have, as their primary action, the ability to induce
altered perceptual states reminiscent of dreams.
•Many of these altered states are accompanied by bright,
colorful changes in the environment and by a plasticity of
constantly changing shapes and color.
•The individual under the influence of these drugs is incapable
of normal decision making, because the drug interferes with
rational thought.
•These compounds are known as hallucinogens or
psychotomimetic drugs.
Lysergic acid diethylamide
 Multiple sites in the CNS are affected by lysergic
acid diethylamide (LSD).
 The drug shows serotonin (5-HT) agonist activity
at presynaptic 5-HT1 receptors in the midbrain,
and also stimulates 5-HT2 receptors.
 Activation of the sympathetic nervous system
occurs, which causes pupillary dilation,
increased blood pressure, and increased body
temperature.
 Taken orally, low doses of LSD can induce
hallucinations with brilliant colors. Mood
alteration also occurs.
 Tolerance and physical dependence have
occurred, but true dependence is rare.
 Adverse effects include hyperreflexia, nausea,
and muscular weakness.
 High doses may produce long-lasting
psychotic changes in susceptible individuals.
 Haloperidol and other neuroleptics can block
the hallucinatory action of LSD and quickly
abort the syndrome.
Tetrahydrocannabinol
 The main psychoactive alkaloid contained in
marijuana is (THC), which is available as dronabinol
 Depending on the social situation, THC can produce
euphoria, followed by drowsiness and relaxation.
 In addition to affecting short-term memory and
mental activity, THC decreases muscle strength and
impairs highly skilled motor activity, such as that
required to drive a car.
 Its wide range of effects include appetite stimulation,
xerostomia, visual hallucinations, delusions, and
enhancement of sensory activity.
 THC receptors, designated CB1 receptors, have
been found on inhibitory presynaptic nerve
terminals that interact synaptically with pyramidal
neurons. CB1 is coupled to a G protein.
 Interestingly, like the endogenous ligands of the
opioid system, endocannabinoids have been
identified in the CNS.
 These compounds, which bind to the CB1
receptors, are membrane-derived and are
synthesized on demand, and they may act as
local neuromodulators
 Dronabinol is indicated as an appetite stimulant
for patients with acquired immunodeficiency
syndrome who are losing weight.
 It is also sometimes given for the severe emesis
caused by some cancer chemotherapeutic agents
.
 The CB1-receptor antagonist, rimonabant is
effective in the treatment of obesity and has been
found to decrease appetite and body weight in
humans.
 Rimonabant has also been found to induce
psychiatric disturbances, such as anxiety and
depression, during clinical trials.
Adverse effects of tetrahydrocannabinol.
Phencyclidine
 Phencyclidine (PCP) inhibits the reuptake of dopamine, 5-
HT, and norepinephrine.
 The major action of phencyclidine is to block the ion
channel regulated by the NMDA subtype of glutamate
receptor.
 Phencyclidine, an analog of ketamine, causes dissociative
anesthesia (insensitivity to pain, without loss of
consciousness) and analgesia. In this state, it produces
numbness of extremities, staggered gait, slurred speech,
and muscular rigidity.
 Sometimes, hostile and bizarre behavior occurs.
 At increased dosages, anesthesia, stupor, or coma result,
but strangely, the eyes may remain open. Increased
sensitivity to external stimuli exists, and the CNS actions
may persist for a week.
Thank you . . .

Weitere ähnliche Inhalte

Was ist angesagt?

ANTI ALZHEIMER'S AGENTS / DRUGS USED IN THE TREATMENT OF ALZHEIMER'S DISEASE
ANTI ALZHEIMER'S AGENTS / DRUGS USED IN THE TREATMENT OF ALZHEIMER'S DISEASEANTI ALZHEIMER'S AGENTS / DRUGS USED IN THE TREATMENT OF ALZHEIMER'S DISEASE
ANTI ALZHEIMER'S AGENTS / DRUGS USED IN THE TREATMENT OF ALZHEIMER'S DISEASEKameshwaran Sugavanam
 
CNS STIMULANTS & NOOTROPICS (COGNITION ENHANCERS) for B.Pharm & Pharm.D
CNS STIMULANTS & NOOTROPICS (COGNITION ENHANCERS) for B.Pharm & Pharm.DCNS STIMULANTS & NOOTROPICS (COGNITION ENHANCERS) for B.Pharm & Pharm.D
CNS STIMULANTS & NOOTROPICS (COGNITION ENHANCERS) for B.Pharm & Pharm.DKameshwaran Sugavanam
 
Cns stimulants
Cns stimulantsCns stimulants
Cns stimulantsraj kumar
 
Anti-Parkinsonism Drugs / Drugs Used in the treatment of Parkinson's Disease
Anti-Parkinsonism Drugs / Drugs Used in the treatment of Parkinson's DiseaseAnti-Parkinsonism Drugs / Drugs Used in the treatment of Parkinson's Disease
Anti-Parkinsonism Drugs / Drugs Used in the treatment of Parkinson's DiseaseKameshwaran Sugavanam
 
Antimanic drugs and its pharmacology
Antimanic drugs and its pharmacologyAntimanic drugs and its pharmacology
Antimanic drugs and its pharmacologyKoppala RVS Chaitanya
 
3.cholinergic drugs
3.cholinergic drugs3.cholinergic drugs
3.cholinergic drugsIAU Dent
 
Narcotic analgesics
Narcotic analgesics Narcotic analgesics
Narcotic analgesics kencha swathi
 
Centrally acting muscle relaxant
Centrally acting muscle relaxant Centrally acting muscle relaxant
Centrally acting muscle relaxant Sujit Karpe
 

Was ist angesagt? (20)

Sedatives & hypnotics
Sedatives & hypnoticsSedatives & hypnotics
Sedatives & hypnotics
 
Cns stimulants
Cns stimulantsCns stimulants
Cns stimulants
 
Antidepressants Pharmacology
Antidepressants  PharmacologyAntidepressants  Pharmacology
Antidepressants Pharmacology
 
ANTIDEPRESSANTS
ANTIDEPRESSANTSANTIDEPRESSANTS
ANTIDEPRESSANTS
 
ANTI ALZHEIMER'S AGENTS / DRUGS USED IN THE TREATMENT OF ALZHEIMER'S DISEASE
ANTI ALZHEIMER'S AGENTS / DRUGS USED IN THE TREATMENT OF ALZHEIMER'S DISEASEANTI ALZHEIMER'S AGENTS / DRUGS USED IN THE TREATMENT OF ALZHEIMER'S DISEASE
ANTI ALZHEIMER'S AGENTS / DRUGS USED IN THE TREATMENT OF ALZHEIMER'S DISEASE
 
CNS STIMULANTS & NOOTROPICS (COGNITION ENHANCERS) for B.Pharm & Pharm.D
CNS STIMULANTS & NOOTROPICS (COGNITION ENHANCERS) for B.Pharm & Pharm.DCNS STIMULANTS & NOOTROPICS (COGNITION ENHANCERS) for B.Pharm & Pharm.D
CNS STIMULANTS & NOOTROPICS (COGNITION ENHANCERS) for B.Pharm & Pharm.D
 
Anticholinergic drugs
Anticholinergic drugsAnticholinergic drugs
Anticholinergic drugs
 
Cns stimulants
Cns stimulantsCns stimulants
Cns stimulants
 
Anti-Parkinsonism Drugs / Drugs Used in the treatment of Parkinson's Disease
Anti-Parkinsonism Drugs / Drugs Used in the treatment of Parkinson's DiseaseAnti-Parkinsonism Drugs / Drugs Used in the treatment of Parkinson's Disease
Anti-Parkinsonism Drugs / Drugs Used in the treatment of Parkinson's Disease
 
Antimanic drugs and its pharmacology
Antimanic drugs and its pharmacologyAntimanic drugs and its pharmacology
Antimanic drugs and its pharmacology
 
3.cholinergic drugs
3.cholinergic drugs3.cholinergic drugs
3.cholinergic drugs
 
Sedative Hypnotic
Sedative HypnoticSedative Hypnotic
Sedative Hypnotic
 
Sedative & hypnotics drugs
Sedative & hypnotics drugsSedative & hypnotics drugs
Sedative & hypnotics drugs
 
Anticonvulsant drugs
Anticonvulsant  drugsAnticonvulsant  drugs
Anticonvulsant drugs
 
Narcotic analgesics
Narcotic analgesics Narcotic analgesics
Narcotic analgesics
 
Hallucinogens pharmacology
Hallucinogens pharmacologyHallucinogens pharmacology
Hallucinogens pharmacology
 
Antidepressant drugs
Antidepressant drugsAntidepressant drugs
Antidepressant drugs
 
Centrally acting muscle relaxant
Centrally acting muscle relaxant Centrally acting muscle relaxant
Centrally acting muscle relaxant
 
Sedatives
SedativesSedatives
Sedatives
 
Antipsychotic drugs
Antipsychotic drugsAntipsychotic drugs
Antipsychotic drugs
 

Ähnlich wie Cns stimulants

cnsstimulants & cognitive enhancers.pptx
cnsstimulants & cognitive enhancers.pptxcnsstimulants & cognitive enhancers.pptx
cnsstimulants & cognitive enhancers.pptxKIRTI GUPTA
 
CNS STIMULANTS & COGNITIVE ENHANCERS
CNS STIMULANTS&COGNITIVE ENHANCERSCNS STIMULANTS&COGNITIVE ENHANCERS
CNS STIMULANTS & COGNITIVE ENHANCERSGHSPL
 
CNS stimulants & cognitive enhancers
CNS stimulants & cognitive enhancersCNS stimulants & cognitive enhancers
CNS stimulants & cognitive enhancersDr.UMER SUFYAN M
 
CNS stimulants and cognitive enhancers
CNS stimulants and cognitive enhancersCNS stimulants and cognitive enhancers
CNS stimulants and cognitive enhancersMahi Yeruva
 
Central Nervous System Agents
Central Nervous System AgentsCentral Nervous System Agents
Central Nervous System AgentsTosca Torres
 
Cnsstimulants.pptx
Cnsstimulants.pptxCnsstimulants.pptx
Cnsstimulants.pptxVimal20002
 
Sedatives and hypnotics
Sedatives  and hypnoticsSedatives  and hypnotics
Sedatives and hypnoticsRohitPal122
 
Cholinergic receptor antagonists presentation
Cholinergic  receptor  antagonists presentationCholinergic  receptor  antagonists presentation
Cholinergic receptor antagonists presentationsigei meshack
 
Central Nervous System Stimulants presentation
Central Nervous System Stimulants presentationCentral Nervous System Stimulants presentation
Central Nervous System Stimulants presentationDixitGoyal10
 
Drugs-acting-on-somatic-nervous-system.pptx
Drugs-acting-on-somatic-nervous-system.pptxDrugs-acting-on-somatic-nervous-system.pptx
Drugs-acting-on-somatic-nervous-system.pptxManish Gautam
 
cns stimulants and drug abuse.pdf
cns stimulants and drug abuse.pdfcns stimulants and drug abuse.pdf
cns stimulants and drug abuse.pdfVijay Salvekar
 
Cns stimulant final ppt july 2021
Cns stimulant final ppt  july 2021Cns stimulant final ppt  july 2021
Cns stimulant final ppt july 2021muthulakshmi623285
 

Ähnlich wie Cns stimulants (20)

cnsstimulants & cognitive enhancers.pptx
cnsstimulants & cognitive enhancers.pptxcnsstimulants & cognitive enhancers.pptx
cnsstimulants & cognitive enhancers.pptx
 
CNS STIMULANTS & COGNITIVE ENHANCERS
CNS STIMULANTS&COGNITIVE ENHANCERSCNS STIMULANTS&COGNITIVE ENHANCERS
CNS STIMULANTS & COGNITIVE ENHANCERS
 
CNS stimulants & cognitive enhancers
CNS stimulants & cognitive enhancersCNS stimulants & cognitive enhancers
CNS stimulants & cognitive enhancers
 
CNS stimulants and cognitive enhancers
CNS stimulants and cognitive enhancersCNS stimulants and cognitive enhancers
CNS stimulants and cognitive enhancers
 
Central Nervous System Agents
Central Nervous System AgentsCentral Nervous System Agents
Central Nervous System Agents
 
2.CNS Stimulants.pptx
2.CNS Stimulants.pptx2.CNS Stimulants.pptx
2.CNS Stimulants.pptx
 
Cnsstimulants.pptx
Cnsstimulants.pptxCnsstimulants.pptx
Cnsstimulants.pptx
 
Sedatives and hypnotics
Sedatives  and hypnoticsSedatives  and hypnotics
Sedatives and hypnotics
 
3 general anethesia
3 general anethesia3 general anethesia
3 general anethesia
 
Epilepsy
EpilepsyEpilepsy
Epilepsy
 
Cholinergic receptor antagonists presentation
Cholinergic  receptor  antagonists presentationCholinergic  receptor  antagonists presentation
Cholinergic receptor antagonists presentation
 
Parasympatholytic drugs
Parasympatholytic drugsParasympatholytic drugs
Parasympatholytic drugs
 
Drug craving
Drug cravingDrug craving
Drug craving
 
Central Nervous System Stimulants presentation
Central Nervous System Stimulants presentationCentral Nervous System Stimulants presentation
Central Nervous System Stimulants presentation
 
Drugs-acting-on-somatic-nervous-system.pptx
Drugs-acting-on-somatic-nervous-system.pptxDrugs-acting-on-somatic-nervous-system.pptx
Drugs-acting-on-somatic-nervous-system.pptx
 
cns stimulants and drug abuse.pdf
cns stimulants and drug abuse.pdfcns stimulants and drug abuse.pdf
cns stimulants and drug abuse.pdf
 
Anticholinergics
AnticholinergicsAnticholinergics
Anticholinergics
 
Local anaesthetics
Local anaestheticsLocal anaesthetics
Local anaesthetics
 
Cns stimulant final ppt july 2021
Cns stimulant final ppt  july 2021Cns stimulant final ppt  july 2021
Cns stimulant final ppt july 2021
 
Antiepileptic drugs
Antiepileptic drugsAntiepileptic drugs
Antiepileptic drugs
 

Mehr von MangeshBansod2

Patient Medication History Interview.pptx
Patient Medication History Interview.pptxPatient Medication History Interview.pptx
Patient Medication History Interview.pptxMangeshBansod2
 
Therapeutic Drug Monitoring.pptx
Therapeutic Drug Monitoring.pptxTherapeutic Drug Monitoring.pptx
Therapeutic Drug Monitoring.pptxMangeshBansod2
 
Medication Adherence.pptx
Medication Adherence.pptxMedication Adherence.pptx
Medication Adherence.pptxMangeshBansod2
 
Drug distribution system in a hospital.pptx
Drug distribution system in a hospital.pptxDrug distribution system in a hospital.pptx
Drug distribution system in a hospital.pptxMangeshBansod2
 
4. Community Pharmacy.pptx
4. Community Pharmacy.pptx4. Community Pharmacy.pptx
4. Community Pharmacy.pptxMangeshBansod2
 
Community Pharmacy Management.pptx
Community Pharmacy Management.pptxCommunity Pharmacy Management.pptx
Community Pharmacy Management.pptxMangeshBansod2
 
Adverse drug reaction- Drug Interaction .pptx
Adverse drug reaction- Drug Interaction .pptxAdverse drug reaction- Drug Interaction .pptx
Adverse drug reaction- Drug Interaction .pptxMangeshBansod2
 
2. Hospital Pharmacy and its Organisation.pptx
2. Hospital Pharmacy and its Organisation.pptx2. Hospital Pharmacy and its Organisation.pptx
2. Hospital Pharmacy and its Organisation.pptxMangeshBansod2
 
1. Hospital and it’s organization.pptx
1. Hospital and it’s organization.pptx1. Hospital and it’s organization.pptx
1. Hospital and it’s organization.pptxMangeshBansod2
 
Aminoglycoside and macrolide antibiotics
Aminoglycoside  and macrolide  antibioticsAminoglycoside  and macrolide  antibiotics
Aminoglycoside and macrolide antibioticsMangeshBansod2
 
Tetracyclins and chloramphenicol
Tetracyclins and chloramphenicolTetracyclins and chloramphenicol
Tetracyclins and chloramphenicolMangeshBansod2
 
Beta lactam antibiotics
Beta lactam antibioticsBeta lactam antibiotics
Beta lactam antibioticsMangeshBansod2
 
Adverse Drug Reaction and its reporting
Adverse Drug Reaction and its reporting Adverse Drug Reaction and its reporting
Adverse Drug Reaction and its reporting MangeshBansod2
 
Organization and function of ans
Organization and function of ansOrganization and function of ans
Organization and function of ansMangeshBansod2
 
Cholinergic system and drugs
Cholinergic system and drugsCholinergic system and drugs
Cholinergic system and drugsMangeshBansod2
 
Anti cholinergic drugs
Anti cholinergic drugsAnti cholinergic drugs
Anti cholinergic drugsMangeshBansod2
 
Adrenergic system and drugs
Adrenergic system and drugsAdrenergic system and drugs
Adrenergic system and drugsMangeshBansod2
 
General pharmacology 2.1 pharmacodynamics
General pharmacology   2.1 pharmacodynamicsGeneral pharmacology   2.1 pharmacodynamics
General pharmacology 2.1 pharmacodynamicsMangeshBansod2
 

Mehr von MangeshBansod2 (20)

Patient Medication History Interview.pptx
Patient Medication History Interview.pptxPatient Medication History Interview.pptx
Patient Medication History Interview.pptx
 
Therapeutic Drug Monitoring.pptx
Therapeutic Drug Monitoring.pptxTherapeutic Drug Monitoring.pptx
Therapeutic Drug Monitoring.pptx
 
Medication Adherence.pptx
Medication Adherence.pptxMedication Adherence.pptx
Medication Adherence.pptx
 
Drug distribution system in a hospital.pptx
Drug distribution system in a hospital.pptxDrug distribution system in a hospital.pptx
Drug distribution system in a hospital.pptx
 
4. Community Pharmacy.pptx
4. Community Pharmacy.pptx4. Community Pharmacy.pptx
4. Community Pharmacy.pptx
 
Community Pharmacy Management.pptx
Community Pharmacy Management.pptxCommunity Pharmacy Management.pptx
Community Pharmacy Management.pptx
 
Adverse drug reaction- Drug Interaction .pptx
Adverse drug reaction- Drug Interaction .pptxAdverse drug reaction- Drug Interaction .pptx
Adverse drug reaction- Drug Interaction .pptx
 
2. Hospital Pharmacy and its Organisation.pptx
2. Hospital Pharmacy and its Organisation.pptx2. Hospital Pharmacy and its Organisation.pptx
2. Hospital Pharmacy and its Organisation.pptx
 
1. Hospital and it’s organization.pptx
1. Hospital and it’s organization.pptx1. Hospital and it’s organization.pptx
1. Hospital and it’s organization.pptx
 
Aminoglycoside and macrolide antibiotics
Aminoglycoside  and macrolide  antibioticsAminoglycoside  and macrolide  antibiotics
Aminoglycoside and macrolide antibiotics
 
Tetracyclins and chloramphenicol
Tetracyclins and chloramphenicolTetracyclins and chloramphenicol
Tetracyclins and chloramphenicol
 
Sulfonamides
SulfonamidesSulfonamides
Sulfonamides
 
Beta lactam antibiotics
Beta lactam antibioticsBeta lactam antibiotics
Beta lactam antibiotics
 
Adverse Drug Reaction and its reporting
Adverse Drug Reaction and its reporting Adverse Drug Reaction and its reporting
Adverse Drug Reaction and its reporting
 
Clinical research
Clinical research Clinical research
Clinical research
 
Organization and function of ans
Organization and function of ansOrganization and function of ans
Organization and function of ans
 
Cholinergic system and drugs
Cholinergic system and drugsCholinergic system and drugs
Cholinergic system and drugs
 
Anti cholinergic drugs
Anti cholinergic drugsAnti cholinergic drugs
Anti cholinergic drugs
 
Adrenergic system and drugs
Adrenergic system and drugsAdrenergic system and drugs
Adrenergic system and drugs
 
General pharmacology 2.1 pharmacodynamics
General pharmacology   2.1 pharmacodynamicsGeneral pharmacology   2.1 pharmacodynamics
General pharmacology 2.1 pharmacodynamics
 

Kürzlich hochgeladen

CYTOGENETIC MAP................ ppt.pptx
CYTOGENETIC MAP................ ppt.pptxCYTOGENETIC MAP................ ppt.pptx
CYTOGENETIC MAP................ ppt.pptxSilpa
 
Bhiwandi Bhiwandi ❤CALL GIRL 7870993772 ❤CALL GIRLS ESCORT SERVICE In Bhiwan...
Bhiwandi Bhiwandi ❤CALL GIRL 7870993772 ❤CALL GIRLS  ESCORT SERVICE In Bhiwan...Bhiwandi Bhiwandi ❤CALL GIRL 7870993772 ❤CALL GIRLS  ESCORT SERVICE In Bhiwan...
Bhiwandi Bhiwandi ❤CALL GIRL 7870993772 ❤CALL GIRLS ESCORT SERVICE In Bhiwan...Monika Rani
 
TransientOffsetin14CAftertheCarringtonEventRecordedbyPolarTreeRings
TransientOffsetin14CAftertheCarringtonEventRecordedbyPolarTreeRingsTransientOffsetin14CAftertheCarringtonEventRecordedbyPolarTreeRings
TransientOffsetin14CAftertheCarringtonEventRecordedbyPolarTreeRingsSérgio Sacani
 
Phenolics: types, biosynthesis and functions.
Phenolics: types, biosynthesis and functions.Phenolics: types, biosynthesis and functions.
Phenolics: types, biosynthesis and functions.Silpa
 
Atp synthase , Atp synthase complex 1 to 4.
Atp synthase , Atp synthase complex 1 to 4.Atp synthase , Atp synthase complex 1 to 4.
Atp synthase , Atp synthase complex 1 to 4.Silpa
 
LUNULARIA -features, morphology, anatomy ,reproduction etc.
LUNULARIA -features, morphology, anatomy ,reproduction etc.LUNULARIA -features, morphology, anatomy ,reproduction etc.
LUNULARIA -features, morphology, anatomy ,reproduction etc.Silpa
 
Molecular markers- RFLP, RAPD, AFLP, SNP etc.
Molecular markers- RFLP, RAPD, AFLP, SNP etc.Molecular markers- RFLP, RAPD, AFLP, SNP etc.
Molecular markers- RFLP, RAPD, AFLP, SNP etc.Silpa
 
THE ROLE OF BIOTECHNOLOGY IN THE ECONOMIC UPLIFT.pptx
THE ROLE OF BIOTECHNOLOGY IN THE ECONOMIC UPLIFT.pptxTHE ROLE OF BIOTECHNOLOGY IN THE ECONOMIC UPLIFT.pptx
THE ROLE OF BIOTECHNOLOGY IN THE ECONOMIC UPLIFT.pptxANSARKHAN96
 
CURRENT SCENARIO OF POULTRY PRODUCTION IN INDIA
CURRENT SCENARIO OF POULTRY PRODUCTION IN INDIACURRENT SCENARIO OF POULTRY PRODUCTION IN INDIA
CURRENT SCENARIO OF POULTRY PRODUCTION IN INDIADr. TATHAGAT KHOBRAGADE
 
Use of mutants in understanding seedling development.pptx
Use of mutants in understanding seedling development.pptxUse of mutants in understanding seedling development.pptx
Use of mutants in understanding seedling development.pptxRenuJangid3
 
Asymmetry in the atmosphere of the ultra-hot Jupiter WASP-76 b
Asymmetry in the atmosphere of the ultra-hot Jupiter WASP-76 bAsymmetry in the atmosphere of the ultra-hot Jupiter WASP-76 b
Asymmetry in the atmosphere of the ultra-hot Jupiter WASP-76 bSérgio Sacani
 
The Mariana Trench remarkable geological features on Earth.pptx
The Mariana Trench remarkable geological features on Earth.pptxThe Mariana Trench remarkable geological features on Earth.pptx
The Mariana Trench remarkable geological features on Earth.pptxseri bangash
 
Zoology 5th semester notes( Sumit_yadav).pdf
Zoology 5th semester notes( Sumit_yadav).pdfZoology 5th semester notes( Sumit_yadav).pdf
Zoology 5th semester notes( Sumit_yadav).pdfSumit Kumar yadav
 
Call Girls Ahmedabad +917728919243 call me Independent Escort Service
Call Girls Ahmedabad +917728919243 call me Independent Escort ServiceCall Girls Ahmedabad +917728919243 call me Independent Escort Service
Call Girls Ahmedabad +917728919243 call me Independent Escort Serviceshivanisharma5244
 
Porella : features, morphology, anatomy, reproduction etc.
Porella : features, morphology, anatomy, reproduction etc.Porella : features, morphology, anatomy, reproduction etc.
Porella : features, morphology, anatomy, reproduction etc.Silpa
 
Genome sequencing,shotgun sequencing.pptx
Genome sequencing,shotgun sequencing.pptxGenome sequencing,shotgun sequencing.pptx
Genome sequencing,shotgun sequencing.pptxSilpa
 
PSYCHOSOCIAL NEEDS. in nursing II sem pptx
PSYCHOSOCIAL NEEDS. in nursing II sem pptxPSYCHOSOCIAL NEEDS. in nursing II sem pptx
PSYCHOSOCIAL NEEDS. in nursing II sem pptxSuji236384
 
Dr. E. Muralinath_ Blood indices_clinical aspects
Dr. E. Muralinath_ Blood indices_clinical  aspectsDr. E. Muralinath_ Blood indices_clinical  aspects
Dr. E. Muralinath_ Blood indices_clinical aspectsmuralinath2
 
Chemistry 5th semester paper 1st Notes.pdf
Chemistry 5th semester paper 1st Notes.pdfChemistry 5th semester paper 1st Notes.pdf
Chemistry 5th semester paper 1st Notes.pdfSumit Kumar yadav
 

Kürzlich hochgeladen (20)

CYTOGENETIC MAP................ ppt.pptx
CYTOGENETIC MAP................ ppt.pptxCYTOGENETIC MAP................ ppt.pptx
CYTOGENETIC MAP................ ppt.pptx
 
Bhiwandi Bhiwandi ❤CALL GIRL 7870993772 ❤CALL GIRLS ESCORT SERVICE In Bhiwan...
Bhiwandi Bhiwandi ❤CALL GIRL 7870993772 ❤CALL GIRLS  ESCORT SERVICE In Bhiwan...Bhiwandi Bhiwandi ❤CALL GIRL 7870993772 ❤CALL GIRLS  ESCORT SERVICE In Bhiwan...
Bhiwandi Bhiwandi ❤CALL GIRL 7870993772 ❤CALL GIRLS ESCORT SERVICE In Bhiwan...
 
TransientOffsetin14CAftertheCarringtonEventRecordedbyPolarTreeRings
TransientOffsetin14CAftertheCarringtonEventRecordedbyPolarTreeRingsTransientOffsetin14CAftertheCarringtonEventRecordedbyPolarTreeRings
TransientOffsetin14CAftertheCarringtonEventRecordedbyPolarTreeRings
 
Phenolics: types, biosynthesis and functions.
Phenolics: types, biosynthesis and functions.Phenolics: types, biosynthesis and functions.
Phenolics: types, biosynthesis and functions.
 
Atp synthase , Atp synthase complex 1 to 4.
Atp synthase , Atp synthase complex 1 to 4.Atp synthase , Atp synthase complex 1 to 4.
Atp synthase , Atp synthase complex 1 to 4.
 
LUNULARIA -features, morphology, anatomy ,reproduction etc.
LUNULARIA -features, morphology, anatomy ,reproduction etc.LUNULARIA -features, morphology, anatomy ,reproduction etc.
LUNULARIA -features, morphology, anatomy ,reproduction etc.
 
Molecular markers- RFLP, RAPD, AFLP, SNP etc.
Molecular markers- RFLP, RAPD, AFLP, SNP etc.Molecular markers- RFLP, RAPD, AFLP, SNP etc.
Molecular markers- RFLP, RAPD, AFLP, SNP etc.
 
THE ROLE OF BIOTECHNOLOGY IN THE ECONOMIC UPLIFT.pptx
THE ROLE OF BIOTECHNOLOGY IN THE ECONOMIC UPLIFT.pptxTHE ROLE OF BIOTECHNOLOGY IN THE ECONOMIC UPLIFT.pptx
THE ROLE OF BIOTECHNOLOGY IN THE ECONOMIC UPLIFT.pptx
 
CURRENT SCENARIO OF POULTRY PRODUCTION IN INDIA
CURRENT SCENARIO OF POULTRY PRODUCTION IN INDIACURRENT SCENARIO OF POULTRY PRODUCTION IN INDIA
CURRENT SCENARIO OF POULTRY PRODUCTION IN INDIA
 
Site Acceptance Test .
Site Acceptance Test                    .Site Acceptance Test                    .
Site Acceptance Test .
 
Use of mutants in understanding seedling development.pptx
Use of mutants in understanding seedling development.pptxUse of mutants in understanding seedling development.pptx
Use of mutants in understanding seedling development.pptx
 
Asymmetry in the atmosphere of the ultra-hot Jupiter WASP-76 b
Asymmetry in the atmosphere of the ultra-hot Jupiter WASP-76 bAsymmetry in the atmosphere of the ultra-hot Jupiter WASP-76 b
Asymmetry in the atmosphere of the ultra-hot Jupiter WASP-76 b
 
The Mariana Trench remarkable geological features on Earth.pptx
The Mariana Trench remarkable geological features on Earth.pptxThe Mariana Trench remarkable geological features on Earth.pptx
The Mariana Trench remarkable geological features on Earth.pptx
 
Zoology 5th semester notes( Sumit_yadav).pdf
Zoology 5th semester notes( Sumit_yadav).pdfZoology 5th semester notes( Sumit_yadav).pdf
Zoology 5th semester notes( Sumit_yadav).pdf
 
Call Girls Ahmedabad +917728919243 call me Independent Escort Service
Call Girls Ahmedabad +917728919243 call me Independent Escort ServiceCall Girls Ahmedabad +917728919243 call me Independent Escort Service
Call Girls Ahmedabad +917728919243 call me Independent Escort Service
 
Porella : features, morphology, anatomy, reproduction etc.
Porella : features, morphology, anatomy, reproduction etc.Porella : features, morphology, anatomy, reproduction etc.
Porella : features, morphology, anatomy, reproduction etc.
 
Genome sequencing,shotgun sequencing.pptx
Genome sequencing,shotgun sequencing.pptxGenome sequencing,shotgun sequencing.pptx
Genome sequencing,shotgun sequencing.pptx
 
PSYCHOSOCIAL NEEDS. in nursing II sem pptx
PSYCHOSOCIAL NEEDS. in nursing II sem pptxPSYCHOSOCIAL NEEDS. in nursing II sem pptx
PSYCHOSOCIAL NEEDS. in nursing II sem pptx
 
Dr. E. Muralinath_ Blood indices_clinical aspects
Dr. E. Muralinath_ Blood indices_clinical  aspectsDr. E. Muralinath_ Blood indices_clinical  aspects
Dr. E. Muralinath_ Blood indices_clinical aspects
 
Chemistry 5th semester paper 1st Notes.pdf
Chemistry 5th semester paper 1st Notes.pdfChemistry 5th semester paper 1st Notes.pdf
Chemistry 5th semester paper 1st Notes.pdf
 

Cns stimulants

  • 2.  These are drugs whose primary action is to stimulate the CNS or to improve specific brain functions.  The CNS stimulants mostly produce a generalized action which may, at high doses, result in convulsions.
  • 4. CONVULSANTS Strychnine -  It is an alkaloid from the seeds of Strychnos nux-vomica, and a potent convulsant.  The convulsions are reflex, tonic-clonic and symmetrical. It labelled as a spinal convulsant because it stimulates the whole cerebrospinal axis.  Strychnine acts by blocking post-synaptic inhibition produced by the inhibitory transmitter glycine.  Due to loss of synaptic inhibition, any nerve impulse becomes generalized, resulting in apparent excitation and convulsions.  There are no valid uses of strychnine now.  Accidental poisonings, especially in children, do occur.  Treatment of poisoning is similar to that of status epilepticus
  • 5. Picrotoxin -  Obtained from ‘fish berries’ of East Indies Anamirta cocculus.  It is a potent convulsant— convulsions are clonic, spontaneous and asymmetrical.  The convulsions are accompanied by vomiting, respiratory and vasomotor stimulation.  Picrotoxin acts by blocking presynaptic inhibition mediated through GABA.  However, it is not a competitive antagonist; does not act on GABA receptor itself, but on a distinct site and prevents Cl¯ channel opening.  Diazepam, which facilitates GABAergic transmission, is the drug of choice for picrotoxin poisoning. CONVULSANTS
  • 6. Pentylenetetrazol (PTZ) -  It is a powerful CNS stimulant, believed to be acting by direct depolarization of central neurones.  However, it has also been shown to interfere with GABAergic inhibition—may be acting in a manner analogous to picrotoxin.  Low doses cause excitation, larger doses produce convulsions which are similar in pattern to those caused by picrotoxin.  Antagonism of PTZ induced convulsions is an established method of testing anticonvulsant drugs in laboratory animals CONVULSANTS
  • 7. ANALEPTICS (Respiratory stimulants)  These are drugs which stimulate respiration and can have resuscitative value in coma or fainting.  They do stimulate respiration in subconvulsive doses, but margin of safety is narrow; the patient may get convulsions while still in coma.  Mechanical support to respiration and other measures to improve circulation are more effective and safe.  The role of analeptics in therapeutics is very limited.  Situations in which they may be employed are: (a) in hypnotic drug poisoning untill mechanical ventilation is instituted. (b) Suffocation on drowning, acute respiratory insufficiency. (c) Apnoea in premature infant. (d) Failure to ventilate spontaneously after general anaesthesia.  However, the overall utility of analeptics is dubious.
  • 8. Doxapram  It acts by promoting excitation of central neurones.  it is more selective for the respiratory centre.  Respiration is stimulated through carotid and aortic body chemoreceptors as well.  Falling BP rises.  Continuous i.v. infusion of doxapram may abolish episodes of apnoea in premature infant not responding to theophylline.
  • 9. PSYCHOSTIMULANTS  the psychomotor stimulants, cause excitement and euphoria, decrease feelings of fatigue, and increase motor activity.  Amphetamines  These are central sympathomimetics.  shows neurologic and clinical effects quite similar to those of cocaine.  Dextroamphetamine is the major member of this class of compounds.  Methamphetamine is a derivative of amphetamine that can be smoked, and it is preferred by many abusers.
  • 10. •The major behavioral effects of amphetamine result from a combination of its dopamine and norepinephrine release-enhancing properties. •Amphetamine stimulates the entire cerebrospinal axis, cortex, brainstem, and medulla. •This leads to increased alertness, decreased fatigue, depressed appetite, and insomnia. •These CNS stimulant effects of amphetamine and its derivatives have led to their use in therapy for hyperactivity in children, narcolepsy, and for appetite
  • 11. Attention deficit hyperactivity disorder (ADHD):  Some young children are hyperkinetic and lack the ability to be involved in any one activity for longer than a few minutes.  Dextroamphetamine and the amphetamine derivative methylphenidate are able to improve attention and to alleviate many of the behavioral problems associated with this syndrome, and to reduce the hyperkinesia that such children demonstrate.  The drug prolongs the patient's span of attention allowing better function in a school atmosphere.
  • 12. Narcolepsy  Narcolepsy is a relatively rare sleep disorder that is characterized by uncontrollable bouts of sleepiness during the day.  It is sometimes accompanied by catalepsy, a loss in muscle control, or even paralysis brought on by strong emotions, such as laughter.  However, it is the sleepiness for which the patient is usually treated with drugs such as amphetamine or methylphenidate. Recently, a newer drug, modafinil and its R-enantiomer derivative, armodafinil, have become available to treat narcolepsy.  Modafinil produces fewer psychoactive and euphoric effects as well as, alterations in mood, perception, thinking, and feelings typical of other CNS stimulants. It does promote wakefulness.
  • 14. Methylphenidate  It is chemically and pharmacologically similar to amphetamine.  Both act primarily by releasing NA and DA in the brain.  Both produce increase in mental activity at doses which have little action on other central and peripheral functions.  Methylphenidate is considered superior to amphetamine for attention deficit hyperkinetic disorder (ADHD) because it causes lesser tachycardia and growth retardation.  Behaviour and learning ability are improved in 3 out of 4 treated children.  It can also be used for concentration and attention defect in adults, and for narcolepsy  Side effects are anorexia, insomnia, growth retardation, abdominal discomfort and bowel upset.
  • 15. Modafinil  This newer psychostimulant is popular with night-shift (call centre) workers and other professionals who want to improve alertness and keep awake.  It is claimed to increase attention span and improve accuracy that has been compromized by fatigue and sleepiness.  Although, modafinil has been shown to inhibit NA and DA uptake as well as alter junctional concentration of glutamate and GABA, its actual mechanism of action is not known.  The approved indications are day-time sleepiness due to narcolepsy, sleep apnoea syndrome and shift-work disorder (SWD).  It has also been found to reduce euphoria produced by cocaine and to suppress cocaine withdrawal symptoms; is being evaluated as a drug to prevent relapse of cocaine dependence.
  • 16. Cocaine  The primary mechanism of action underlying the central and peripheral effects of cocaine is blockade of reuptake of the monoamines (norepinephrine, serotonin, and dopamine) into the presynaptic terminals from which these neurotransmitters are released.  potentiates and prolongs the CNS and peripheral actions of these monoamines.  the prolongation of dopaminergic effects in the brain's pleasure system (limbic system) produces the intense euphoria that cocaine initially causes.  Chronic intake of cocaine depletes dopamine. This depletion triggers the vicious cycle of craving for cocaine that temporarily relieves severe depression
  • 17. Actions: Cocaine  CNS: The behavioral effects of cocaine result from powerful stimulation of the cortex and brainstem.  Cocaine acutely increases mental awareness and produces a feeling of well-being and euphoria similar to that caused by amphetamine.  Like amphetamine, cocaine can produce hallucinations and delusions of paranoia or grandiosity.  Cocaine increases motor activity, and at high doses, it causes tremors and convulsions,
  • 18. Cocaine  Sympathetic nervous system: Peripherally, cocaine potentiates the action of norepinephrine, and it produces the fight or flight syndrome characteristic of adrenergic stimulation.  This is associated with tachycardia, hypertension, pupillary dilation, and peripheral vasoconstriction. Recent evidence suggests that the ability of baroreceptor reflexes to buffer the hypertensive effect may be impaired.  Hyperthermia: Cocaine is unique among illicit drugs in that death can result not only as a function of dose but also from the drug's propensity to cause hyperthermia.
  • 19. Cocaine  Therapeutic uses: Cocaine has a local anesthetic action that represents the only current rationale for the therapeutic use of cocaine.  For example, cocaine is applied topically as a local anesthetic during eye, ear, nose, and throat surgery.  Whereas the local anesthetic action of cocaine is due to a block of voltage-activated sodium channels,  an interaction with potassium channels may contribute to the ability of cocaine to cause
  • 20. Pharmacokinetics: Cocaine  Cocaine is often self-administered by chewing, intranasal snorting, smoking, or intravenous (IV) injection.  The peak effect occurs at 15 to 20 minutes after intranasal intake of cocaine powder, and the disappears in 1 to 1.5 hours.  the onset of action is most rapid, the potential for overdosage and dependence is greatest with IV injection and crack smoking.  Cocaine is rapidly de-esterified and demethylated to benzoylecgonine, which is excreted in the urine.  Detection of this substance in the urine identifies a user.
  • 21. Adverse effects: Cocaine  Anxiety  Depression  Toxic effects Major effects of cocaine use.
  • 22. Caffeine  The methylxanthines include theophylline which is found in tea; theobromine , found in cocoa; and caffeine.  Out of the three naturally occurring methylxanthines, only caffeine is used as a CNS stimulant.  Mechanism of action: translocation of extracellular calcium, increase in cyclic adenosine monophosphate and cyclic guanosine monophosphate caused by inhibition of phosphodiesterase, and blockade of adenosine receptors.
  • 23. Actions: Caffeine  CNS: The caffeine contained in one to two cups of coffee (100–200 mg) causes a decrease in fatigue and increased mental alertness as a result of stimulating the cortex and other areas of the brain.  Consumption of 1.5 g of caffeine (12 to 15 cups of coffee) produces anxiety and tremors.  The spinal cord is stimulated only by very high doses of caffeine.  Tolerance can rapidly develop to the stimulating properties of caffeine; withdrawal consists of feelings of fatigue and sedation.  Cardiovascular system: A high dose of caffeine has positive inotropic and chronotropic effects on the heart.
  • 24.  Diuretic action: Caffeine has a mild diuretic action that increases urinary output of sodium, chloride, and potassium.  Gastric mucosa: Because all methylxanthines stimulate secretion of hydrochloric acid from the gastric mucosa, individuals with peptic ulcers should a  Pharmacokinetics: The methylxanthines are well absorbed orally. Caffeine distributes throughout the body, including the brain.  The drugs cross the placenta to the fetus and is secreted into the mother's milk.  All the methylxanthines are metabolized in the liver, generally by the CYP1A2 pathway, and the Caffeine
  • 25.  Adverse effects: Moderate doses of caffeine cause insomnia, anxiety, and agitation.  A high dosage is required for toxicity, which is manifested by emesis and convulsions.  Lethargy, irritability, and headache occur in users who have routinely consumed caffeine . Caffeine
  • 26. •A few drugs have, as their primary action, the ability to induce altered perceptual states reminiscent of dreams. •Many of these altered states are accompanied by bright, colorful changes in the environment and by a plasticity of constantly changing shapes and color. •The individual under the influence of these drugs is incapable of normal decision making, because the drug interferes with rational thought. •These compounds are known as hallucinogens or psychotomimetic drugs.
  • 27. Lysergic acid diethylamide  Multiple sites in the CNS are affected by lysergic acid diethylamide (LSD).  The drug shows serotonin (5-HT) agonist activity at presynaptic 5-HT1 receptors in the midbrain, and also stimulates 5-HT2 receptors.  Activation of the sympathetic nervous system occurs, which causes pupillary dilation, increased blood pressure, and increased body temperature.  Taken orally, low doses of LSD can induce hallucinations with brilliant colors. Mood alteration also occurs.
  • 28.  Tolerance and physical dependence have occurred, but true dependence is rare.  Adverse effects include hyperreflexia, nausea, and muscular weakness.  High doses may produce long-lasting psychotic changes in susceptible individuals.  Haloperidol and other neuroleptics can block the hallucinatory action of LSD and quickly abort the syndrome.
  • 29. Tetrahydrocannabinol  The main psychoactive alkaloid contained in marijuana is (THC), which is available as dronabinol  Depending on the social situation, THC can produce euphoria, followed by drowsiness and relaxation.  In addition to affecting short-term memory and mental activity, THC decreases muscle strength and impairs highly skilled motor activity, such as that required to drive a car.  Its wide range of effects include appetite stimulation, xerostomia, visual hallucinations, delusions, and enhancement of sensory activity.
  • 30.  THC receptors, designated CB1 receptors, have been found on inhibitory presynaptic nerve terminals that interact synaptically with pyramidal neurons. CB1 is coupled to a G protein.  Interestingly, like the endogenous ligands of the opioid system, endocannabinoids have been identified in the CNS.  These compounds, which bind to the CB1 receptors, are membrane-derived and are synthesized on demand, and they may act as local neuromodulators
  • 31.
  • 32.  Dronabinol is indicated as an appetite stimulant for patients with acquired immunodeficiency syndrome who are losing weight.  It is also sometimes given for the severe emesis caused by some cancer chemotherapeutic agents .  The CB1-receptor antagonist, rimonabant is effective in the treatment of obesity and has been found to decrease appetite and body weight in humans.  Rimonabant has also been found to induce psychiatric disturbances, such as anxiety and depression, during clinical trials.
  • 33. Adverse effects of tetrahydrocannabinol.
  • 34. Phencyclidine  Phencyclidine (PCP) inhibits the reuptake of dopamine, 5- HT, and norepinephrine.  The major action of phencyclidine is to block the ion channel regulated by the NMDA subtype of glutamate receptor.  Phencyclidine, an analog of ketamine, causes dissociative anesthesia (insensitivity to pain, without loss of consciousness) and analgesia. In this state, it produces numbness of extremities, staggered gait, slurred speech, and muscular rigidity.  Sometimes, hostile and bizarre behavior occurs.  At increased dosages, anesthesia, stupor, or coma result, but strangely, the eyes may remain open. Increased sensitivity to external stimuli exists, and the CNS actions may persist for a week.
  • 35. Thank you . . .